Benefits for Health System

  • Based on available data, the cost burden of diabetes and its complications in Europe is significant and growing. In many countries, diabetes is responsible for more than 10% of total healthcare spending1. Insulin delivery complications such as:

    • Emergency care
    • Unplanned admissions to hospital
    • More frequent GP and Nurse visits
    • Increased referrals to specialist care
    • Time off work

    will make a significant contribution to the overall cost.

  • Examples of cost (estimated average cost Europe)

    • Ambulance attendance for hypoglycaemia £2632
    • Foot care - England and Wales3
      • Foot ulceration:
        • Direct inpatient cost £19,383,505
        • Community and outpatient costs £150,063,769
      • Minor amputation:
        • Direct inpatient cost £13,497,572
      • Major amputation:
        • Direct inpatient cost £13,134,651
  • The cost of diabetes associated foot ulcers and amputations to England and Wales NHS is estimated to be £196,079,497

    • Diabetes associated kidney failure– England and Wales4, 5
      • Haemodialysis £187,687,579
      • Kidney transplant £60,442,480
  • The cost of diabetes associated kidney failure to England and Wales NHS is estimated to be £248,130,055

    • May help improve clinical outcomes with lower overall costs.

      • Patients with lipohypertrophy, compared with those without, use on average 15 units of insulin per day more.6
      • Following multimodal injection technique intervention, patients reduced insulin usage by 2 units per day and lowered HbA1c by 0,58%7
        Measurable Clinical Imorovements


    • 1 The European Coalition for Diabetes (IDF Europe, FEND, PCDE and EURADIA). Policy Puzzle. Is Europe Making Progress? 3rd dition (2011)
    • 2 Farmer AJ1, Brockbank KJ, Keech ML, England EJ, Deakin CD. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med. 2012 Nov;29(11):1447-50. doi: 10.1111/j.1464-5491.2012.03657.x.
    • 3 M Kerr et al. NHS Diabetes Foot Care for People with Diabetes. March 2012. The Case for Change. Insight Health Economics
    • 4 Health and Social Care Information Centre 2013 National Diabetes Audit - 2011-12. Available at <> Last accessed 28/08/14
    • 5 The Renal Association. UK Renal Registry 16th Annual Report Southmead Hospital. 2013
    • 6 Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013 Oct;39(5):445-53. doi: 10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22.
    • 7 Grassi G, Scuntero P, Trepiccioni R, et al. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1:145‐150.
Stay connected